Baker McKenzie Baker McKenzie
How Can We Help?
  • Home
  • Expertise
  • 医疗与生命科学
Language:
中文(简体)

医疗与生命科学

blue and violet wire-shaped patterns against a blue background
Insight | Topic

Healthcare & Life Sciences Hub

Stay apprised on key market trends, risks, opportunities and legal issues through our dedicated resources hub.
Read More

Healthcare and life sciences companies face immense opportunity and disruption. The increasing innovation in new product breakthroughs; interplay between drugs, devices and tech; cost pressures; and demand for patient centricity have created a melting pot for agility and change.

Businesses turn to Baker McKenzie to enter new markets, maximize operational efficiencies, build a long-term pipeline of innovative products and demonstrate efficacy. We provide commercial legal advice to help anticipate and manage new risk and avoid disconnect between global strategy and the law enabling your company to provide better care to patients across the globe.

Visit InsightPlus for our latest legal updates covering Healthcare & Life Sciences developments across the globe

Insight | 宣传册
Looking Ahead: Business Impacts of the Trump Administration
With Donald Trump now in office, Baker McKenzie practitioners outline the business implications that we expect to see across a range of areas.
Insight | 书籍
Ukrainian Laws in Wartime
Our guide provides an overview of the key features of wartime legislation.
Insight | 客户/法律动态
Three Driving Forces for Healthcare and Life Sciences Transactions 
The healthcare and life sciences sector is expected to lead in deal activity this year. Companies in the sector will need to consider all factors before proceeding with a deal.
Insight | 书籍
Quick Guide to Market Access in the Latin America Healthcare and Life Sciences Sector
This guide provides initial insights into accessing public health systems and the regulations governing available drugs in Latin America. 
Insight | 书籍
Doing Business in the United Arab Emirates 2024
Comprehensive guide to understanding the current investment and legal landscape in the UAE.
Insight | 客户/法律动态
UK General Election Manifesto and Policy Tracker
A summary of the policies outlined in the Conservative and Labour manifestos and an indication of what the potential impact on businesses and individuals may be.
Insight | 宣传册
Unlocking and Accelerating Growth: Healthcare and Life Sciences in Asia Pacific
Healthcare and life sciences breakthroughs offer opportunities to meet patient needs and create value, but rising costs and market uncertainty also apply significant pressure to operations.
Insight | 客户/法律动态
WHO Releases AI Ethics and Governance Guidance for Large Multimodal Models
The WHO guidance summarizes the broad applications of LMMs in the healthcare industry, including recommendations for governments, and for public health and medical purposes.
Insight | 宣传册
The Year Ahead: Global Disputes Forecast 2024 Report
Our seventh annual report provides detailed analysis of disputes trends to prepare your organization for 2024.
Insight | 客户/法律动态
Supporting clients to seize Korea’s substantial opportunities
Our lawyers discuss the abundant opportunities that Korea presents and how the JV supports clients with their Korea inbound and outbound investments and business expansion. 
Insight | 书籍
Guide to IPOs for Biotech and Pharma Companies
Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.
View All Insight
News | 交易公告
Baker McKenzie Advised hearX in its Merger with Eargo, Creating LXE Hearing
The deal is the first notable combination for the over-the-counter hearing aid market since the FDA established the regulatory category in 2022.
News | 本所新闻
奋迅·贝克麦坚时资本市场业务部迎来精英团队加入，实力得到进一步提升
贝克・麦坚时律师事务所（以下简称“贝克·麦坚时”）及其联营合作伙伴奋迅律师事务所（以下简称“奋迅”）今日宣布，由合伙人欧阳丹（Dan Ouyang）律师、刘泳晖（Winfield Lau）律师、李可（Ronnie Li）律师以及高级顾问包珍珍（Zhenzhen ...
News | 交易公告
Baker McKenzie legal advisor to the banks in Asker´s IPO on Nasdaq Stockholm
Asker is a leading provider of medical products and solutions in Europe.
News | 本所新闻
Baker McKenzie Strengthens Transactional Team With Addition of Michal Berkner in London
Michal is dual-qualified in the UK and the US, and her addition to the Firm will significantly expand and enhance its Transactional practice and offering in the UK and US markets.
News | Case Announcement
Baker McKenzie Assists Mission Barns in Obtaining Precedent Setting FDA Clearance
Mission Barns is the first company in the world to receive regulatory clearance for cell-cultivated pork fat.
News | 交易公告
Deal Digest – January/February 2025
M&A, private equity and other complex transactions from across the globe
News | 交易公告
Baker McKenzie Advises Crisalix and its Shareholders on its Acquisition by BID Equity
The acquisition aims to combine Crisalix's technological expertise with BID Equity's financial resources to promote international growth and innovative product development.
News | 交易公告
Baker McKenzie Advises Incyte in Its AI-focused Research Collaboration with Genesis Therapeutics
The partnership offers Incyte the opportunity to leverage GEMS to accelerate the advancement of critical treatments for patients with severe diseases.
News | 交易公告
Baker McKenzie Advises Galapagos on its Separation into Two Publicly Traded Entities
Through the separation, Galapagos will create a new entity dedicated to building a pipeline of innovative medicines through strategic transactions.
News | Insight
Baker McKenzie Annual Disputes Survey: Technology-Related Issues Top 2025 Disputes Risk
The report looks at the disputes landscape for the year ahead across various sectors and offers actionable insights to help organizations prepare for the future.
News | Press Coverage
Deal Digest – October / November 2024
M&A, private equity and other complex transactions from across the globe
浏览全部新闻

Ranked in the Top 4 Law Firms in the World for Life Sciences, Chambers Global

Americas

  • Ranked in Healthcare: Pharmaceutical/Medical Products Regulatory, Chambers USA 2024 (District of Columbia)
  • Band 1 for Life Sciences, Chambers Latin America 2024 (Mexico)
  • Band 2 for Life Sciences and Healthcare, Chambers Latin America 2024 (Peru)
  • Tier 1 for Life Sciences and Healthcare, Legal 500 Latin America 2024 (Argentina)
  • Tier 1 for Life Sciences, Legal 500 Latin America 2024 (Mexico)
  • Tier 2 for Life Sciences, Legal 500 Latin America 2024 (Colombia)
  • Impact Deal of the Year - Poseida Therapeutics/Takeda, LMG Life Sciences Americas 2022 (US)
  • Impact Deal of the Year - Pfizer/Trillium Therapeutics, LMG Life Sciences Americas 2022 (Canada)
  • FDA Regulatory Firm to Watch, LMG Life Sciences Awards 2020 (US)
  • Licensing and Collaborations Recommended Firm, LMG Life Sciences 2021 and 2020 (US)

Europe, Middle East and Africa

  • Band 1 for Life Sciences, Chambers Europe 2024 (Hungary)
  • Band 2 for Life Sciences, Chambers Europe 2024 (Germany and Spain)
  • Listed for Healthcare & Life Sciences (Industry Focus and Regulatory), Legal 500 EMEA 2024 (Germany)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 EMEA 2024 (France, Italy, Spain)
  • Tier 2 for Healthcare & Life Sciences (Industry Focus), Legal 500 UK 2024 (London)
  • Law Firm of the Year for Health and Research, Top Legal Industry Awards (Italy)
  • Regulatory Firm of the Year, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Türkiye Firm of the Year, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)
  • Impact Deal - Vifor Pharma/Sanifit, LMG Life Sciences EMEA 2022 (Türkiye) - Esin Attorney Partnership (a Member Firm of Baker McKenzie International)

Asia Pacific

  • Band 1 for Life Sciences (Asia Pacific Region), Chambers Global 2014 to 2024 Chambers Asia Pacific 2014 to 2024
  • Band 2 for Life Sciences, Chambers Asia Pacific 2024 (Australia)
  • Band 2 for Life Sciences (International Firms), Chambers Greater China Region 2024 (China)
  • Tier 2 for Healthcare and Life Sciences (Foreign Firms), Legal 500 Asia Pacific 2023 (China)

How We Can Help

Explore Healthcare & Life Sciences

Healthcare and Life Sciences video still

About Us

Learn about our Global Healthcare & Life Sciences Industry Group in five minutes.


Three driving forces for HLS transactions

Three Driving Forces for Healthcare and Life Sciences Transactions

Valuations, interest rates and global regulatory compliance influencing transactions in sector in 2025


The Impact of Tariffs on the Life Sciences Industry

Summary of key takeaways on the tariff landscape, particularly in pharmaceuticals and medical devices


Healthtech and Biotech M&A

The healthcare tech and biotech industries shifted fundamentally during the pandemic. Enthusiasm for dealmaking continues to be a growth area.

>> 16-minute listen

Flares of different colored light against a black background

Guide to IPOs for Biotech and Pharma Companies

Biotech and pharma companies undertaking capital raisings can approach the world’s capital markets in various ways.


Global Healthcare & Life Sciences Webinar Series

Aims to share legal industry insights and provide practical guidance in the context of today's evolving world.


Key Contacts